Promising pharmaceutical agents proving as doping productsPerformance enhancing qualities of non-steroidal and tissue-selective anabolic agents such as Selective Androgen Receptor Modulators (SARMs) are prompting a demand high, according to researchers from the German Sport University Cologne in Germany.

SARMs represent a promising class of therapeutics for treating diseases such as benign prostatic hyperplasia (BPH), sarcopenia, osteoporosis, and cancer cachexia and gaining popularity in the sports doping community as they provide benefits of traditional anabolic/androgenic steroids such as testosterone with fewer unwanted side effects.

Mario Thevis, Ph.D. remarked that the study demonstrates that the misuse of therapeutics by athletes, without clinical approval, cannot be dismissed.